Skip to content
Clinical Trials – home
Therapeutic area

Endocrine disorders – page 21

  • 504 clinical trials
  • 189 recruiting
  • 213 conditions
  • 25 countries

Conditions in this area

213 conditions with trials, the busiest first

Clinical trials in Endocrine disorders

504 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

504 clinical trials

Diabetic foot

Not yet recruiting

Study on AUP1602-C for Treating Non-Healing Diabetic Foot Ulcers in Patients

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:AUP1602-C
  • Sponsor:Aurealis Oy

Hyperadrenocorticism

Not yet recruiting

Study on Using [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Patients with Cushing's Disease

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Fluoroethyltyrosine F-18
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Neuroblastoma

Not yet recruiting

Study of Anti-GD2-800CW for Imaging in Children with Neuroblastoma

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years
  • Substances:Anti-GD2-800CW
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Endocrine ophthalmopathy

Not yet recruiting

Study on the Effects of TOUR006 for Adults with Thyroid Eye Disease

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Human IgG2 monoclonal antibody against IL-6
  • Sponsor:Tourmaline Bio Inc.

Paraganglion neoplasm+2

Not yet recruiting

Study on the Effectiveness of Lutetium (177Lu) Edotreotide for Patients with Neuroendocrine Tumors and Other SSTR-Positive Tumors

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177LU) edotreotide
  • Sponsor:Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.

Thyroid mass+4

Not yet recruiting

Study Comparing Radiofrequency Ablation and Sodium Iodide (131I) for Treating Hyperthyroidism in Patients with Overactive Thyroid Nodules

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Sodium iodide (131I)
  • Sponsor:Rijnstate Ziekenhuis Stichting

Type 1 diabetes mellitus

Not yet recruiting

A study evaluating a combination of glucagon and insulin lispro to improve insulin absorption in adults with Type 1 diabetes

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Glucagon
  • Sponsor:St. Olavs Hospital HF

Diabetic foot

Not yet recruiting

Study on the Safety and Effects of Udonitrectag for Treating Diabetic Foot Ulcers in Patients

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Udonitrectag
  • Sponsor:Mimetech S.r.l.

Polycystic ovarian syndrome

Not yet recruiting

Study on Metformin and Metformin Hydrochloride for Overweight Adults with Polycystic Ovary Syndrome

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Metformin
  • Sponsor:HUS-Yhtymae

Diabetic foot+1

Not yet recruiting

Study on the Effectiveness of Autologous Bone Marrow-Derived Mononuclear Cells and Angioplasty in Diabetic Patients with Chronic Limb-Threatening Ischemia

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Autologous bone marrow-derived mononuclear cells
  • Sponsor:Institute For Clinical And Experimental Medicine

Type 1 diabetes mellitus

Not yet recruiting

Study on Verapamil and Exenatide for Adults with Type 1 Diabetes to Measure Changes in Beta Cell Mass

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Exenatide
  • Sponsor:Stichting Radboud universitair medisch centrum

Endocrine ophthalmopathy

Not yet recruiting

Study on the Effects of VRDN-003 for Patients with Active Thyroid Eye Disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:VRDN-003
  • Sponsor:Viridian Therapeutics Inc.

Substances studied in this area

The therapies tested most often in Endocrine disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.